SciDEX — Wiki (100 pages)

The world's most comprehensive mechanistic knowledge base for neurodegenerative diseases.

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

🧪 Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease (NCT05531656)KG

clinical · 1,758 words · 63 hyp41 ana49 exp

Scientific World Model

What is the Scientific World Model?

⚙️ Synaptic Vesicle Trafficking in Parkinson's DiseaseKG

⚙️ Synaptic Dysfunction in NeurodegenerationKG

⚙️ Synaptic Plasticity Deficits in NeurodegenerationKG

🏢 Alzheimer's Disease Synaptic Repair and Neuroprotection CompaniesKG

⚙️ Synaptic Dysfunction PathwayKG

⚙️ microglial-synaptic-pruning-dysregulationKG

⚙️ Synaptic Failure in NeurodegenerationKG

⚙️ Synaptic Vesicle CycleKG

⚙️ Synaptic Vesicle TraffickingKG

⚙️ Synaptic Loss in Alzheimer's Disease PathwayKG

⚙️ Synaptic Loss and Dysfunction PathwayKG

⚙️ synaptic-vesicle-trafficking-pathwayKG

⚙️ Synaptic Dysfunction in Parkinson's DiseaseKG

⚙️ Activity-Dependent Synaptic Plasticity in NeurodegenerationKG

⚙️ Synaptic Dysfunction Comparison in Neurodegenerative DiseasesKG

⚙️ Synaptic Loss in Alzheimer's DiseaseKG

📊 Synaptic Biomarkers in NeurodegenerationKG

⚙️ synaptic-vesicle-cycling-neurodegenerationKG

🏢 Parkinson's Disease Synaptic Repair and Preservation Companies

Synaptic Vesicle Trafficking Dysfunction Hypothesis in Parkinson's DiseaseKG

⚙️ Synaptic Dysfunction in Alzheimer's DiseaseKG

⚙️ Synaptic Vesicle Cycle in NeurodegenerationKG

Synaptic Vesicle CycleKG

⚙️ Synaptic Organization in NeurodegenerationKG

🔬 Dentate Mossy Fiber to CA3 Synaptic NeuronsKG

⚙️ Synaptic Dysfunction in Neurodegenerative DiseasesKG

⚙️ Synaptic TransmissionKG

⚙️ Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in NeurodegenerationKG

AAIC 2026: Synaptic Dysfunction and Neural Circuit AlterationsKG

⚙️ Synaptic Dysfunction in Corticobasal SyndromeKG

⚙️ Synaptic Dysfunction in Progressive Supranuclear PalsyKG

⚙️ Synaptic Dysfunction in 4R-TauopathiesKG

💊 Synaptic Protection TherapiesKG

💡 Synaptic Complement InhibitorKG

🏥 Synaptic Dysfunction in 4R-Tauopathies ComparisonKG

💡 USP13 Inhibitor for Mitophagy and Synaptic ProteostasisKG

⚙️ Synaptic Spine Degradation Pathway in Alzheimer's DiseaseKG

💊 Section 195: Advanced Synaptic Plasticity and Network Modulation in CBS/PSPKG

📊 NPTX2 (Neuronal Pentraxin 2) - Synaptic BiomarkerKG

🔬 Synaptic BoutonsKG

🧬 PROSAP1 - Proline-Rich Synaptic-Associated Protein 1 (SHANK2)KG

🧪 Synaptic Loss in Multiple System Atrophy (NCT05121012)KG

🔬 Synaptic Loss in NeurodegenerationKG

🧪 Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease (NCT05531656)KG

🏢 AD Microglial Phagocytosis and Synaptic Pruning CompaniesKG

⚙️ Synaptic Dysfunction in Neurodegeneration - SfN 2026 ResearchKG

🧬 RIMS1 — Regulating Synaptic Membrane Exocytosis 1KG

📊 SV2A - Synaptic Vesicle Protein BiomarkerKG

🔬 Synaptic Vesicle Glycoprotein 2B ProteinKG

⚙️ Synaptic Plasticity PathwayKG